Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
The Bamboo Works

Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock

Key takeaways:

  • Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market
  • The company was valued at around 9 billion yuan after its latest funding round
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.